Efficacy and safety of montelukast add-on therapy in allergic rhinitis

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 32, Issue 9, 2010, Pages 669-674

  Modgill, V ^a   Badyal, Dinesh K ^a   Verghese, A ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CETIRIZINE; FLUTICASONE; MONTELUKAST;

ABDOMINAL PAIN; ADD ON THERAPY; ADULT; ALLERGIC RHINITIS; ARTICLE; BACTERIAL INFECTION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HUMAN; LEG PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NOSE CONGESTION; NOSE DISEASE; PSYCHOMOTOR ACTIVITY; PURULENT NOSE DISCHARGE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SCORING SYSTEM; SEDATION; SIDE EFFECT; TASTE DISCRIMINATION;

ACETATES; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADULT; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; CETIRIZINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; NASAL SPRAYS; PROSPECTIVE STUDIES; QUINOLINES; RHINITIS;

EID: 79954477572     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2010.32.9.1533686     Document Type: Article

References (19)

1. U.S. Department of Health and Human Services. Agency for Healthcare Research and Quality. Management of allergic and nonallergic rhinitis. May 2002. AHQR publication 02:E023, Boston, MA. Summary, Evidence Report/Technology Assessment: No 54. Available at http://www.ahrq.gov/clinic/epcsums/rhinsum.htm (Accessed on April 23, 2010).
2. de Godoy. M.O., Campos, R.A., Antila, M. et al. Futura study: Evaluation of efficacy and safety of rupatadine fumarate in the treatment of persistent allergic rhinitis. Braz J Otorhinolaryngol 2009, 75(5): 673-9.
3. Naclerio, R.M. The role of histamine in allergic rhinitis. J Allergy Clin Immunol 1990, 86(4, Pt. 2): 628-32.
4. Peters-Golden, M., Henderson, W.R. Jr. The role of leukotrienes in allergic rhinitis. Ann Allergy Asthma Immunol 2005, 94(6): 609-18.
5. Daykewicz, M.S., Fineman, S., Skoner, D.P. et al. Diagnosis and management of rhinitis: Complete guidelines of the joint task force on practice parameters in allergy asthma and immunology. American academy of allergy asthma and immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998, 81(5, Pt. 2): 478-518.
6. Tattersfields, A.E., Harrison, T.W., Hubbard, R.B., Mortimer, K. Safety of inhaled corticosteroids. Proc Am Thorac Soc 2004, 1(3): 171-5.
7. Gengo, F.M., Gabos, C. Antihistamines, drowsiness and psychomotor impairment: Central nervous system effect of cetrizine. Ann Allergy 1987, 59(6, Pt. 2): 53-7.
8. David, V.K., Badyal, D.K., Varghese, A., Alexander, E. Comparative effect of newer antihistamines on psychomotor functions in Indian population. JK Science 2010, 12(1): 15-8.
9. Pullerits, T., Praks, L., Skoogh, B.E., Ani, R., Lötvall, J. Randomized placebo-controlled trial comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med 1999, 159(6): 1814-8.
10. Meltzer, E.O., Malmstrom, K., Lu, S. et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial. J Allergy Clin Immunol 2000, 105(5): 917-22.
11. Allergic rhinitis and its impact on asthma (ARIA) guidelines by WHO 1999. Available at www.whiar.com (Accessed on April 23, 2010).
12. Lorenzo, G., Pacor, M.L., Pellitteri, M.E. et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetrizine, fluticasone plus montelukast and cetrizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy 2004, 34(2): 259-67.
13. Pullerits, T., Praks, L., Ristioja, V., Lötvall, J. Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2002, 109(6): 949-55.
14. Wilson, A.M., Orr, L.C., Sims, E.J., Lipworth, B.J. Effects of monotherapy with intra-nasal corticosteroid or combined oral histamine and leukotriene receptor antagonists in seasonal allergic rhinitis. Clin Exp Allergy 2001, 31(1): 61-8.
15. Meltzer, E.O. Evaluation of the optimal oral antihistamine for patients with allergic rhinitis. Mayo Clin Proc 2005, 80(9): 1170-6.
16. Philip, G., Malmstrom, K., Hampel, F.C. et al. Montelukast for treating seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy 2002, 32(7): 1020-8.
17. Mucha, S.M., de Tineo, M., Naclerio, R.M., Baroody, F.M. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg 2006, 132(2):164-72.
18. Seitz, A.R., Nanez, J.E., Holloway, S.R., Watanabe, T. Visual experience can substantially alter critical flicker fusion thresholds. Hum Psychopharmacol Clin Exp 2005, 20(1): 55-60.
19. Modgil, V., Badyal, D., Verghese, A. Rare case of fluticasone allergy - A case report. Clin Researcher 2009, 1(2): 75.